]>
IRCT201310089662N8 IRCT 2013-12-04 Isfahan University of Medical Sciences Evaluation of the effects of sour tea on lipid profile, insulin resistance, oxidative stress, and inflammatory markers in adult patients with metabolic syndrome Evaluation of the effects of Hibiscus sabdariffa on lipid profile, insulin resistance, oxidative stress, and hs-CRP level in adult patients with metabolic syndrome 2013-05-22 anticipated 40 Complete https://irct.ir/trial/10229 interventional Randomization: Randomized, Blinding: Double blinded, Placebo: Used, Assignment: Parallel, Purpose: Treatment. N/A metabolic syndrome. Intervention 1: In group 1 capsule daily treatment will sour tea. Once a day after breakfast. Intervention 2: In the control group taking placebo capsules daily, after breakfast.
public
scientific Sedigheh Asgary
Khorram Street, Jomhoori Square
Isfahan Iran (Islamic Republic of) +98 31 1335 9090 sasgary@yahoo.com Isfahan Cardiovascular Research Center, Applied Physiology Research Center, Isfahan University of Me Iran (Islamic Republic of) Inclusion criteria: Patients with metabolic syndrome according to the criteria of panel The Adult Treatment Panel III (ATP III) treatment groups were 2005 adults.These criteria include having 3 of the 5 criteria: Abdominal obesity (waist circumference more 102 cm in men and than 88 cm In women );Decrease in plasma HDL-C (men less than 40 mg/dl and in women less than 50 mg/dl); Plasma hypertriglyceridemia (greater than 150 mg/dl); Hypertension (systolic blood pressure greater than or equal to 130 mm Hg or diastolic blood pressure greater than or equal to 85 mm Hg);And abnormal blood glucose (fasting blood glucose equal to or greater than 100). exclusion criteria:People with diseases such as diabetes type 1 or 2;Thyroid disorders; nephrotic syndrome; Liver or kidney disease;Insulin, oral antidiabetic drugs;Drugs which affect blood lipid levels, such as statins;Oral contraceptive pills, hormones such as estrogen and progesterone;Smoking, alcohol and drugs;Pregnancy and lactation; drug allergy. 18 years 70 years Both E78.8 Other disorders of lipoprotein metabolism Treatment - Drugs Placebo In group 1 capsule daily treatment will sour tea. Once a day after breakfast In the control group taking placebo capsules daily, after breakfast Low-density lipoprotein (LDL). Timepoint: Baseline and one month after intervention. Method of measurement: mg/dL - enzymatic - photometric. Triglyceride (TG). Timepoint: Baseline and one month after intervention. Method of measurement: mg/dL - enzymatic - photometric. Total cholesterol (TC). Timepoint: Baseline and one month after intervention. Method of measurement: mg/dL - enzymatic - photometric. High-density Lipoprotein(HDL). Timepoint: Baseline and one month after intervention. Method of measurement: mg/dL - enzymatic - photometric. VLDL. Timepoint: Baseline and one month after intervention. Method of measurement: mg/dL - enzymatic - photometric. Apo-A. Timepoint: Baseline and one month after intervention. Method of measurement: mg/dL - enzymatic - photometric. َApo- B. Timepoint: Baseline and one month after intervention. Method of measurement: mg/dL - enzymatic - photometric. Insulin. Timepoint: Baseline and one month after intervention. Method of measurement: mg/dL - enzymatic - photometric. FBS. Timepoint: Baseline and one month after intervention. Method of measurement: mg/dL - enzymatic - photometric. Hs-CRP. Timepoint: Baseline and one month after intervention. Method of measurement: ng/dl/ Elisa. MDA. Timepoint: Baseline and one month after intervention. Method of measurement: ng/dl/ Elisa. BMI. Timepoint: Baseline and one month after intervention. Method of measurement: W/M2. Isfahan University of Medical Sciences Approved 2010-09-23 Isfahan University of Medical Sciences Hezar jirib St. Isfahan Isfahan, Iran, Islamic Republic Of Isfahan Iran (Islamic Republic of)